Evolution of induction chemotherapy for non-small cell lung cancer over the last 30 years: A surgical appraisal.
| Author | |
|---|---|
| Abstract |
:
Induction chemotherapy (ICT) is supposed to reduce the risk of micrometastatic progression and improve resectability of non-small cell lung cancer (NSCLC). However, best indications for ICT strategy remain unclear in published meta-analyses. Based on this observation, an evaluation of daily practice is of importance. Therefore, we reviewed indications and efficacy time trends in our 30-year series. |
| Year of Publication |
:
2015
|
| Journal |
:
Thoracic cancer
|
| Volume |
:
6
|
| Issue |
:
6
|
| Number of Pages |
:
731-40
|
| ISSN Number |
:
1759-7706
|
| URL |
:
https://doi.org/10.1111/1759-7714.12250
|
| DOI |
:
10.1111/1759-7714.12250
|
| Short Title |
:
Thorac Cancer
|
| Download citation |
